Second wave of Covid-19 to take a toll on Indian healthcare system: Fitch

India remains badly placed to tackle the rapid spread of Covid-19 despite several reforms and the unprecedented crisis has highlighted the need to increase investments in the healthcare sector

Lok Nayak Jai Prakash (LNJP) hospital
Patients suffering from the coronavirus disease get treatment at the casualty ward in Lok Nayak Jai Prakash (LNJP) hospital, amidst the spread of the disease in New Delhi (Photo: Reuters)
ANI
3 min read Last Updated : Apr 16 2021 | 11:10 AM IST

India remains badly placed to tackle the rapid spread of coronavirus despite several reforms and the unprecedented crisis has highlighted the need to increase investments in the healthcare sector, Fitch Solutions said on Friday.

"The continued lack of medical funding and healthcare infrastructure inform our view for the potential epidemic to be worse if it is not adequately contained," it said.

With 8.5 hospital beds per 10,000 population and 8 physicians per 10,000, the country's healthcare sector is not equipped for such a crisis. Moreover, the significant inefficiency, dysfunctioning and acute shortage of the healthcare delivery systems in public sector do not match upwith the growing needs of the population.

In addition, said Fitch, more than 80 per cent of the population still does not have any significant health insurance coverage and about 68 per cent of the population has limited or no access to essential medicines.

The low level of public spending on health is both a cause and an exacerbating factor accounting for the poor quality, limited reach and insufficient public provisioning of healthcare.

"Dealing with the Covid-19 pandemic has brought out the critical importance of public sector in health provisioning," said Fitch.

The country of 1.35 billion people has administered 80.9 million vaccine doses until April, the most after the United States and China, but it lags far behind in immunisations per capita.

India, the world's biggest vaccine maker, expanded its inoculation programme to include everyone above the age of 45. But so far it has vaccinated only about one in 25 people compared with nearly one in two in Britain and one in three in the UnitedStates.

Fitch said India's soaring virus cases puts its position as a global supplier at risk -- the country has had to hold back vaccine exports in order to maintain domestic supply. The supply issues will significantly affect emerging Asian countries like Sri Lanka and Bangladesh that fall within the COVAX plan.

India's economy had returned to functioning normally by the second half of 2020. However, over recent weeks, the virus has started spreading rapidly, partly due to complacency on the social distancing measures and mask wearing policies.

With daily Covid-19 cases crossing the grim milestone of 103,558, several hospitals across the country are stretched beyond their capacities in handling the rising burden of the highly infectious disease.

States such as Maharashtra, Delhi, Chennai along with Punjab and Karnataka bearing the maximum load of the pandemic are already falling short of health infrastructure and equipment ranging from oxygen to ventilators.

Prime Minister Narendra Modi in a review meeting stated that mortality under all circumstances should be avoided by ramping up healthcare infrastructure, availability of oxygen, ventilators besides required logistics, and ensuring that clinical management protocols are followed across all hospitals as well as for those in-home care.

Concerned over the rising burden of thepandemic, said Fitch, states are now revamping their health infrastructure in order to tackle the rising number of patients.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusFitchIndian healthcare system

First Published: Apr 16 2021 | 11:06 AM IST

Next Story